Dermavant Sciences: Dermavant Announces Appointment of Michael Swartzburg as Chief Financial Officer
Dermavant Sciences: Dermavant Announces Appointment of Michael Swartzburg as Chief Financial Officer - Over 20 Years of Combined Experience in Global Finance Leadership, Audit, and Advisory Roles in the Biopharmaceutical Industry - Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the appointment of Michael Swartzburg as Chief Financial Officer. Mr. Swartzburg brings extensive finance expertise, with over 20 years of leadership within the biotechnology and healthcare space. ...
Source: finanznachrichten.de